itMSC, bone marrow-derived mesenchymal stem cells for cardiovascular diseases
itMSC (ischemic tolerant mesenchymal stem cells) are bone marrow-derived mesenchymal stem cells indicated for the treatment of cardiovascular diseases, such as acute myocardial infarction (AMI), chronic heart failure (CHF) and peripheral artery disease (PAD). These cells are unique in their low immunogenicity, notable ability to migrate towards site of injury, and by the high levels of growth and transcription factors they secrete.
itMSC-treated AMI patients demonstrated elevated left ventricular ejection fraction (LVEF) and reduced inflammation compared to control groups.
Read More
Product Information for
itMSC, bone marrow-derived mesenchymal stem cells for cardiovascular diseases
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access